TransMedics Group, Inc. (TMDX) is in Healthcare, Medical Devices, based in United States, listed on NasdaqGM. Market cap 2.73B USD. 52-week range 60.10 to 156.00 USD. Trailing P/E 20.5. Data as of 2026-10-09.
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation ...